Adenoid Cystic Carcinoma Organization International
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 10,994 | 9,887 | 1,107 | 100.4 | — |
| 2012 | 29,141 | 17,678 | 11,463 | 63.9 | — |
| 2013 | 8,206 | 17,901 | −9,695 | 56.6 | — |
| 2014 | 149,224 | 20,776 | 128,448 | 123.0 | — |
| 2015 | 3,877 | 17,325 | −13,448 | 138.2 | — |
| 2016 | 19,832 | 17,776 | 2,056 | 134.4 | — |
| 2017 | 30,279 | 6,446 | 23,833 | 411.5 | — |
| 2018 | 18,346 | 10,250 | 8,096 | 268.2 | — |
| 2019 | 22,784 | 15,071 | 7,713 | 188.3 | — |
| 2020 | 26,122 | 4,699 | 21,423 | 656.8 | — |
| 2021 | 46,209 | 10,082 | 36,127 | 349.4 | — |
| 2022 | 35,638 | 16,256 | 19,382 | 229.1 | — |
| 2023 | 64,310 | 7,837 | 56,473 | 566.5 | — |
In its most recent public year (2023), this organization brought in $56,473 more than it spent. Its reserves stood at about 566.5 months of spending, up from 100.4 in 2011.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Adenoid Cystic Carcinoma Organization International's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works